Learn more

UNIV MICHIGAN REGENTS

Overview
  • Total Patents
    2,613
  • GoodIP Patent Rank
    715
  • Filing trend
    0.0%
About

UNIV MICHIGAN REGENTS has a total of 2,613 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIV CORNELL, UNIV NEW YORK STATE RES FOUND and UNIV MICHIGAN.

Patent filings per year

Chart showing UNIV MICHIGAN REGENTSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Shaomeng 200
#2 Forrest Stephen R 191
#3 Aguilar Angelo 77
#4 Liu Liu 63
#5 Mceachern Donna 59
#6 Zhou Bing 54
#7 Chinnaiyan Arul 52
#8 Sakamoto Jeffrey 51
#9 Yang Chao-Yie 50
#10 Sun Duxin 49

Latest patents

Publication Filing date Title
US2021096111A1 Progressive Cellular Architecture For Microfabricated Gas Chromatograph
WO2021081517A1 An integrated smart point-of-care biosensor for whole-blood liquid biopsies
US2021121112A1 Uroflowmetry systems having wearable uroflowmeters, and methods of operating the same
WO2021081141A1 Glucosylceramide synthase inhibitors and therapeutic methods using the same
US2021115664A1 Acoustic device thermoforming
WO2021077110A1 Biomaterial sensor systems
US2021114553A1 Passenger State Modulation System For Passenger Vehicles Based On Prediction And Preemptive Control
US2021119420A1 Nanocrystal surface-emitting lasers
US2021110524A1 Non-Destructive Imaging Techniques For Integrated Circuits And Other Applications
WO2021071836A1 Spectrally and coherently combined laser array
US2021048067A1 Axially Compliant Bearing For Precision Positioning
WO2021067811A1 Self-healing metal-ligand polymeric materials
WO2021067667A1 Methods for determining responsiveness to anti-tumor necrosis factor therapy in the treatment of psoriasis
US2021094942A1 Biocatalytic synthesis of cryptophycin anticancer agents
US2021098725A1 Organic ternary solar cells and vacuum-deposited method
WO2021067167A1 Clostrodioides difficile treatment
WO2021062328A1 Automated can message translator
US2021089803A1 Digital foveation for machine vision
US2021110932A1 Methods and Systems to Predict Macular Edema in a Patient's Eye Following Cataract Surgery
WO2021061789A1 Compositions and methods for increasing the efficacy of immunotherapies and vaccines